<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><description>BiG, Biologics Innovation Group. To nurture an Eco-system for Biologics innovation and imprint China on Global map.</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 08 Jun 2021 15:31:49 +0800</pubDate><image><url>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</url><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>渤健新药满城风雨，靶向TREM2会是AD新希望么？</title><link>https://mp.weixin.qq.com/s/rfjtN1j9_cAOMrVzm3A4Qg</link><description></description><content:encoded><![CDATA[渤健新药满城风雨，靶向TREM2会是AD新希望么？]]></content:encoded><pubDate>Tue, 08 Jun 2021 14:24:23 +0800</pubDate></item><item><title>FDA批准AD新药Aduhelm，会是饮鸠止渴么？</title><link>https://mp.weixin.qq.com/s/5dfVOaUpIt8IeUXosEjkaA</link><description></description><content:encoded><![CDATA[FDA批准AD新药Aduhelm，会是饮鸠止渴么？]]></content:encoded><pubDate>Tue, 08 Jun 2021 14:24:23 +0800</pubDate></item><item><title>对话80后创新者｜未来3-5年，AI制药界的最大突破？</title><link>https://mp.weixin.qq.com/s/Ery9jLraEl0EEkp5VbDZNA</link><description></description><content:encoded><![CDATA[对话80后创新者｜未来3-5年，AI制药界的最大突破？]]></content:encoded><pubDate>Mon, 07 Jun 2021 17:44:56 +0800</pubDate></item><item><title>如何提高ADC药物的实体瘤穿透性？</title><link>https://mp.weixin.qq.com/s/d4-Vwcr37-eVi2xqJlU-bg</link><description></description><content:encoded><![CDATA[如何提高ADC药物的实体瘤穿透性？]]></content:encoded><pubDate>Mon, 07 Jun 2021 17:44:56 +0800</pubDate></item><item><title>唇枪舌战！八位药企掌舵人激辩Biotech2.0</title><link>https://mp.weixin.qq.com/s/X73k5gifn1eEm_R5pXnB_Q</link><description></description><content:encoded><![CDATA[唇枪舌战！八位药企掌舵人激辩Biotech2.0]]></content:encoded><pubDate>Fri, 04 Jun 2021 22:25:18 +0800</pubDate></item><item><title>NDFC 6周年 | “冲云破雾”年会精彩预告</title><link>https://mp.weixin.qq.com/s/M-RNMgxwW7ovlirxT4o3FQ</link><description></description><content:encoded><![CDATA[NDFC 6周年 | “冲云破雾”年会精彩预告]]></content:encoded><pubDate>Fri, 04 Jun 2021 22:25:18 +0800</pubDate></item><item><title>对话沈琳：从PI视角看双抗在胃肠肿瘤的疗效和难点</title><link>https://mp.weixin.qq.com/s/AYXhZuQhs4IbO0vIT689Ew</link><description></description><content:encoded><![CDATA[对话沈琳：从PI视角看双抗在胃肠肿瘤的疗效和难点]]></content:encoded><pubDate>Fri, 04 Jun 2021 18:19:15 +0800</pubDate></item><item><title>VEGFR-2单抗的进阶多面杀癌之路</title><link>https://mp.weixin.qq.com/s/BzM4p5_9uQB_LpGlfubMYQ</link><description></description><content:encoded><![CDATA[VEGFR-2单抗的进阶多面杀癌之路]]></content:encoded><pubDate>Fri, 04 Jun 2021 18:19:15 +0800</pubDate></item><item><title>肿瘤免疫明星靶点之CD137：双抗及Combo策略</title><link>https://mp.weixin.qq.com/s/YdR1b6qq0NWLT_qLzFHKPg</link><description></description><content:encoded><![CDATA[肿瘤免疫明星靶点之CD137：双抗及Combo策略]]></content:encoded><pubDate>Thu, 03 Jun 2021 16:04:44 +0800</pubDate></item><item><title>招聘｜董晨院士领衔，上海市免疫治疗创新研究院广募英才！</title><link>https://mp.weixin.qq.com/s/qgoAFZjnTwTvdbkzUZh3eg</link><description></description><content:encoded><![CDATA[招聘｜董晨院士领衔，上海市免疫治疗创新研究院广募英才！]]></content:encoded><pubDate>Thu, 03 Jun 2021 16:04:44 +0800</pubDate></item><item><title>四种靶向肿瘤相关巨噬细胞的策略</title><link>https://mp.weixin.qq.com/s/QyUe5OhxSGqo9JYlXx0fXA</link><description></description><content:encoded><![CDATA[四种靶向肿瘤相关巨噬细胞的策略]]></content:encoded><pubDate>Wed, 02 Jun 2021 17:45:44 +0800</pubDate></item><item><title>License-in重磅药，搅动研发格局！</title><link>https://mp.weixin.qq.com/s/54j2e45o0Jg_UGtVEx6AVw</link><description></description><content:encoded><![CDATA[License-in重磅药，搅动研发格局！]]></content:encoded><pubDate>Wed, 02 Jun 2021 17:45:44 +0800</pubDate></item><item><title>新药论坛三箭齐发，吐槽大会爆笑江湖｜BiG年会DAY 2</title><link>https://mp.weixin.qq.com/s/xQolJgZbYKTqNpZ5ovgnKA</link><description></description><content:encoded><![CDATA[新药论坛三箭齐发，吐槽大会爆笑江湖｜BiG年会DAY 2]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:58:13 +0800</pubDate></item><item><title>从AMG510加速上市，看KRAS-不可成药靶点的逆袭之路！</title><link>https://mp.weixin.qq.com/s/Bpdqk8GR566u0nSeGzXY5Q</link><description></description><content:encoded><![CDATA[从AMG510加速上市，看KRAS-不可成药靶点的逆袭之路！]]></content:encoded><pubDate>Mon, 31 May 2021 17:34:04 +0800</pubDate></item><item><title>张文宏领衔燃BiG，八位研发掌门人再决BB-King之巅｜年会DAY1</title><link>https://mp.weixin.qq.com/s/5Blg-JmmoWFneysMBn7IwQ</link><description></description><content:encoded><![CDATA[张文宏领衔燃BiG，八位研发掌门人再决BB-King之巅｜年会DAY1]]></content:encoded><pubDate>Sun, 30 May 2021 10:26:32 +0800</pubDate></item><item><title>江河入海，东海论药！第七届BiG年会终极预告</title><link>https://mp.weixin.qq.com/s/aTKc113cxfe31o3j1pBuAA</link><description></description><content:encoded><![CDATA[江河入海，东海论药！第七届BiG年会终极预告]]></content:encoded><pubDate>Thu, 27 May 2021 12:52:34 +0800</pubDate></item></channel></rss>